BRIEF-AstraZeneca Provides Update on Evusheld US EUA
AstraZeneca PLC: * UPDATE ON EVUSHELD US EUA
* TO CONTINUE TO WORK WITH FDA, OTHER HEALTH AUTHORITIES TO COLLECT, ASSESS, SHARE RELEVANT DATA REGARDING EVUSHELD AND SARS-COV-2 VARIANTS * EVUSHELD REMAINS AUTHORISED IN OTHER COUNTRIES WHERE IT IS APPROVED FOR COVID PRE-EXPOSURE PROPHYLAXIS,TREATMENT, INCLUDING EU AND JAPAN Source text for Eikon: Further company coverage:
ALSO READ
-
Ranveer Singh-starrer 'Dhurandhar' to release in Japan on July 10
-
ROI-Japan faces unique oil, bond, FX triple whammy: McGeever
-
India's Quality Leap: IFQM Leads CXO Study Mission to Japan with JUSE
-
New Zealand local council rejects plan for 'comfort women' statue after Japan protest
-
Asian Games could be moved to pre-Olympic year after 2026 edition in Japan: Reports
Google News